Mylan Wrings Another $13.7M From GSK In Generic Paxil Row
A New Jersey federal judge on Thursday granted Mylan Inc. supplemental damages of $13.7 million in the generic-drug maker's feud with GlaxoSmithKline PLC over the sale of generic versions of GSK's...To view the full article, register now.
Already a subscriber? Click here to view full article